StocksGilead Sciences IncGILD

GILD

Gilead Sciences Inc

67.27 -0.07 (-0.10%)
Precios retrasados ofrecidos por el índice NASDAQ, en USD Mercado cerrado
Invertir
V
67.17
C
67.33
Publicación incluida
eToro Team
🚨 Attention In our efforts to keep improving your trading and investing experience at eToro, we sometimes need to shut down some features for a short period of time. Bearing this in mind, we'd like to inform you that core functionalities may be intermittently unavailable between 11:00 PM GMT on... Mostrar más Traducir
Me gusta ComentarCompartir
Mostrar más comentarios2 de 33
1 respuesta
null
.
Canal de mercado
Destacado
DeepNews
$GILD (Gilead Sciences Inc) FDA Puts Clinical Hold On Gilead's Magrolimab/Azacitidine Combo Trials In Blood Cancer Settings The FDA has placed a partial clinical hold on Gilead Sciences Inc's (NASDAQ: GILD) studies evaluating the combination of magrolimab plus azacitidine. Due to an apparent... Mostrar más Traducir
Cosmin Gheorghe Cosma
DeepNews
$GILD (Gilead Sciences Inc) FDA puts partial clinical hold on Gilead's magrolimab + azacitidine studies Gilead Sciences (GILD) announces that the FDA has placed a partial clinical hold on studies evaluating the combination of magrolimab plus azacitidine due to an apparent seekingalpha.com/news/3791611-fda-puts-partial-clinical-hold-on-gileads-magrolimab-azacitidine-studies Traducir
DeepNews
$GILD (Gilead Sciences Inc) Gilead (GILD) Drug Gets FDA Nod for Non-Hospitalized COVID Patients Gilead (GILD) gets FDA approval for label expansion of Veklury for the treatment of non-hospitalized patients at high risk for COVID-19 disease progression. www.entrepreneur.com/article/414768 Traducir
Tufa-Dragos Adrian
📌People who want everything immediately get nothing at all.📌 ➕ Follow me to get daily EPS and "Ex-Dividend" dates ➕ Average risk score - ONLY 3. Portfolio results: 🔒 2021: ➕14.06 🔒 🔒 2020: ➕36.45% gain in only 6 months 🔒 Comment with the company name and I will write the results. Copy... Mostrar más Traducir